Gene Therapy Reverses Erectile Dysfunction
Gene therapy delivery of nerve growth factors reverses erectile dysfunction in animal model.
|
Consumers Advised Not To Use The Following Products For Treatment Of Erectile Dysfunction
Health Canada is advising consumers not to use the following product for treatment of erectile dysfunction due to concerns about possible side-effects.
|
PC Detect For Prostate Cancer Screening Available
PC Detect, Panacea Pharmaceuticals' prostate cancer screening test, is now available from Panacea Laboratories.
|
Novacea, Schering-Plough To DevelopA Novel Treatment For Prostate Cancer
Novacea and Schering-Plough Corporation have entered into an exclusive worldwide license agreement for the development and commercialization of Asentar for prostate cancer treatment.
|
June Is Prostate Cancer Awareness Month
Prostate cancer is the most common type of cancer diagnosed in men and the second leading cause of cancer death in Kansas.
|
Free Men's Health Screenings During Fathers' Day
Fathers' Day fun family event will offer free blood pressure, stroke, prostate and body mass index screenings for men.
|
Testosterone May Help Men With Multiple Sclerosis
Clinical trial now underway to confirm that the female hormone estriol combats the effects of multiple sclerosis in women, a recently completed UCLA pilot study shows promise for the use of testosterone to combat the effects of the disease in men.
|
Group To Evaluate Prostate Cancer DNA Vaccine
Cancer Center Karolinska have jointly developed a DNA Vaccine to stimulate a patient's immune system to fight and kill prostate cancer cells remaining in the body after removal or irradiation of the prostate gland.
|
Screening men over 65 for abdominal aortic aneurysms could save lives
Between 5% and 10% of men aged 65 to 79 have abdominal aortic aneurysms, but don't know it.
|
Health Risk Alert For 'True Man' And 'Energy Max' Products
The Food and Drug Administration is advising consumers not to purchase or use "True Man" or "Energy Max" products promoted and sold as dietary supplements throughout the United States.
|
Prostate Cancer Clinical Study Resumes At Virginia Urology Center
EDAP TMS S.A. announced the continuation of its US Phase II/III clinical trial with treatment of an additional two patients at Virginia Urology Center, Richmond, Virginia.
|
More Benefits Of Exercise In Men, For Prostate And Sexuality
Protection against heart disease, stroke, diabetes, obesity, hypertension, memory loss, colon cancer, fractures, and depression should be enough to get men exercising.
|
EDAP, Duke Restart Ablatherm-HIFU Localized Prostate Cancer Clinical Study
This technology offers an alternative to other approved therapies for prostate cancer and may be effective in selected individuals as a primary therapy.
|
New Prostate Cancer Treatment Wins Operations Research Award
The unique application of operations research to the treatment of prostate cancer allowed Memorial Sloan-Kettering Cancer Center to better Fortune 500 companies and win an international competition for best project by an organization.
|
Better Blood Test for Prostate Cancer
New studies of a blood protein recently identified at Johns Hopkins, early prostate cancer antigen-2 (EPCA-2), may change the way men are screened for prostate cancer - a disease that kills tens of thousands of men every year.
|
Illinois Department Of Health Raises Awareness About Black Men's Health
Illinois Department of Public Health encouraged African-American men to take charge of their health by making better choices and taking advantage of testing for certain diseases and conditions.
|
Quality Of Life After Common Treatments For Prostate Cancer
A rigorous study of quality of life in patients who underwent one of three common prostate cancer treatments found that each treatment affected men's lives in different ways.
|
New Blood Test For Prostate Cancer Better Detects The Disease
A new prostate cancer research has been published by Onconome, Inc., which conducted a breakthrough prostate cancer study at The Johns Hopkins School of Medicine.
|
No-Scalpel Vasectomies By Skilled Surgeons May Speed Recovery
Although no-scalpel vasectomies are becoming more popular among physicians and patients, there are no definitive statistics to confirm the superiority of this choice, and a new review's main conclusion is to underline the importance of training.
|
FDA Accepts Satraplatin NDA For Filing And Grants Priority Review Status
FDA has accepted for filing the Company's New Drug Application for satraplatin in combination with prednisone for patients with hormone-refractory prostate cancer whose prior chemotherapy has failed.
|
Imaging method shows if treatment for advanced prostate cancer is working
Researchers have identified a new imaging technique that can measure the effectiveness of treatment for prostate cancer that has spread to the bones.
|
Early-stage sperm cells created from human bone marrow
Researchers say they have found a way to create early-stage sperm cells from human bone marrow.
|
Measuring calcium intake can help to identify osteoporosis in men with prostate cancer
Measuring a man's daily calcium intake is an effective way of identifying prostate cancer patients with a higher than average risk of osteoporosis.
|
PSA doubling predicts prostate cancer recurrence
A detectable level of prostate-specific antigen (PSA) is the first indicator of recurrent prostate cancer after radical prostatectomy.
|
Significant Prostate Cancer Risk Factors Identified
A study has identified seven genetic risk factors-DNA sequences carried by some people but not others-that predict risk for prostate cancer.
|
FDA Committee Reviewed Provenge for Hormone Refractory Prostate Cancer
There is substantial evidence of efficacy and safety of PROVENGE (sipuleucel-T) for the treatment of patients with asymptomatic, metastatic, androgen-independent (also known as hormone refractory) prostate cancer.
|
Multiple genetic risk factors for prostate cancer
Seven genetic risk factors predict risk for prostate cancer, including DNA sequences carried by some people but not others.
|
Two New Studies Test Varying Treatments for Enlarged Prostate
Unpleasant urinary symptoms caused by an enlarged prostate are also known as benign prostatic hyperplasia (BPH).
|
Age-Specific PSA Cut-Offs Avoid Unnecessary Prostate Biopsies in Older Men
The introduction of age-specific cut-offs for prostate-specific antigen (PSA) levels used in prostate cancer screening will reduce the number of unnecessary prostate biopsies in older men who naturally have higher levels of PSA than younger men.
|
Links Between Prostate Cancer Treatment, Periodontal Disease
Androgen deprivation therapy (ADT) has become a valuable weapon in the fight against prostate cancer.
|
Biopsy May Underestimate Prostate Cancer in Obese and Overweight Men
Obese and overweight men who are diagnosed with prostate cancer by biopsy are more likely than healthy weight men to actually have a more aggressive case of the disease than the biopsy results would indicate.
|
Rice bran could reduce risk of intestinal cancer
A study by biomedical scientists at the University of Leicester has revealed for the first time that rice bran could reduce the risk of intestinal cancer.
|
Erectile dysfunction in diabetes is due to defect in brain
How erectile dysfunction interacts with diabetes is another step in uncovering the link between the two disorders, and may lead to improved efficacy in erectile dysfunction treatments.
|
Soy is protective against localized prostate cancer
Soy offers no protection against advanced prostate cancer.
|
'Manly Men' Bounce Back Better From Injury
This masculine identity often associated with men in the armed forces and other high-risk occupations may actually encourage and quicken a man's recovery from serious injuries.
|
Health-care inequities underscore racial disparities in prostate cancer
Improving access to healthcare system may benefit African-American prostate cancer patients more than educational or motivational interventions, according to a new study.
|
Health disparities in prostate cancer stem from lack of care
Decreasing the rates of prostate cancer among black men may require improving access to routine health care, rather than increased education about the disease.
|
New Treatment for Testicular Cancer
Testicular cancer is a disease in which malignant (cancer) cells form in the tissues of one or both testicles.
|
Tea Antioxidant Plus Celebrex May Fight Prostate Cancer
A component of green tea, combined with low doses of the cox2 inhibitor painkiller Celebrex, may be able to slow prostate cancer growth.
|
A key to male fertility
Understand the overall mechanisms involved in sexual maturation in boys. We can now identify a new player involved in the control of male fertility.
|
